Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126613732 | 12661373 | 2 | F | 201605 | 20160609 | 20160817 | 20160901 | EXP | US-RELYPSA-RLY2016000986 | RELYPSA | 92.05 | YR | F | Y | 0.00000 | 20160901 | PH | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126613732 | 12661373 | 1 | PS | VELTASSA | PATIROMER | 1 | Oral | 8.4 G, QD | VPSW | 0 | 8.4 | G | ORAL SUSPENSION | ||||||
126613732 | 12661373 | 2 | SS | HYDROCODONE | HYDROCODONE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126613732 | 12661373 | 1 | Hyperkalaemia |
126613732 | 12661373 | 2 | Spinal column stenosis |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126613732 | 12661373 | Fatigue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126613732 | 12661373 | 1 | 20160317 | 0 |